Stock Market News and Research Tools
In the world of modern investing, you can’t afford to fly blind. Whether you’re managing a $5 million book or a $5 billion fund, portfolio monitoring has to be fast, accurate, and, above all, actionable. It’s not enough to just “track” performance—you need to understand it in real time, analyze it from multiple angles, and…
Shares of Kiri Industries Ltd crashed 11% on 30 May after the company signed a Share Purchase Agreement (SPA) with Zhejiang Longsheng Group to sell its 37.57% stake in DyStar for a base price of $676.26 million. At the current currency rate, this amount is around Rs 5,765 crore, which is larger than the company’s…
Great Start to the Week: After a bit of a lackluster finish to last week, we jumped right back on track for Monday’s premarket report with four potential targets that all turned in some really impressive performances. There were big movers all the way across the board, and we hope some of our readers were able to take…
It isn’t just the well-known blue-chip stocks that are starting to get some wind at their tail. The mid-cap growth stocks are also participating in the rally. And as the TSX Index’s hot run (it’s up close to 15% year to date, ahead of the S&P 500, which is up 10%) continues, I think Canadian…
Register for a Free Live Training The Hot Stocks Outlook uses VantagePoint’s market forecasts that are up to 87.4% accurate, demonstrating how traders can improve their timing and direction. In this week’s video, VantagePoint Software reviews forecasts for SPDR SPY($SPY), Duke Energy ($DUK), Pacira Pharmaceuticals($PCRX), Global Foundries ($GFS), Taiwan Semiconductors Manufacturing ($TSM), Humana ($HUM), Oracle…
By Jessica DiNapoli NEW YORK (Reuters) -Nestle’s new food brand for people taking weight-loss drugs like Wegovy will note that the meals are high in protein, fiber and nutrients, but will not name the blockbuster medications, a company executive told Reuters. The world’s largest food maker is keeping the names of the drugs off the…